Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients

Clinical trial NCT03539406 · COMPLETED

Trial details

NCT number: NCT03539406
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ovarian Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Primary Peritoneal Carcinoma

Start date: 2019-06-04
Primary completion: 2023-05-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.